DoMore Diagnostics

DoMore Diagnostics uses digital biomarkers developed with AI to make personalized treatment decisions simple and accessible for cancer patients. Its unique digital biomarkers predict patient outcomes from routine tumor tissue slides and can be seamlessly integrated into pathologists’ existing workflow. The lead product

DoMore Diagnostics is a company in health.

Profile

DoMore Diagnostics uses digital biomarkers developed with AI to make personalized treatment decisions simple and accessible for cancer patients. Its unique digital biomarkers predict patient outcomes from routine tumor tissue slides and can be seamlessly integrated into pathologists’ existing workflow. The lead product Histotype Px® Colorectal is a CE-IVDD marked outcome prediction marker for stage […]

Within the health space, the company focuses on its core offering rather than a broad product line.

Its current recorded stage is Creative Destruction Lab alumni company.

Website: www.domorediagnostics.com